<DOC>
	<DOCNO>NCT00137761</DOCNO>
	<brief_summary>The purpose study find activity combination docetaxel Iressa metastatic pancreatic cancer .</brief_summary>
	<brief_title>Docetaxel Combination With Iressa Previously Treated Patients With Pancreatic Cancer</brief_title>
	<detailed_description>Iressa take orally daily without interruption . Docetaxel administer intravenously weekly two every three week . Patients also receive dexamethasone night prior , morning , even docetaxel treatment help prevent allergic reaction . Every week chemotherapy give , blood test vital sign take . After first 6 week therapy CT scan ( radiological procedure ) do assess progress disease . If cancer respond treatment unacceptable side effect occur , treatment Iressa docetaxel continue . CT scan ( radiological procedure ) perform week 12 every 9 week thereafter monitor progress disease .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Metastatic pancreatic carcinoma ( exclude pancreatic endocrine tumor ) ; histologic confirmation either primary metastatic site . ECOG performance status &lt; 1 &gt; 4 week since completion previous chemotherapy &gt; 4 week since participation investigational drug study Peripheral neuropathy grade &lt; 1 Patients must fail gemcitabinecontaining regimen administer metastatic , adjuvant , locally advanced setting . Absolute neutrophil count ( ANC ) &gt; 1,500/mm3 Hemoglobin &gt; 9.0gm/dl Platelets &gt; 100,000/mm3 Total bilirubin &lt; 2.0mg/dl AST alkaline phosphatase &lt; 5 x upper limit normal ( ULN ) Albumin &gt; 2.5gm/dl CA 199 &gt; 1.5 x ULN Prior therapy taxane epidermal growth factor receptor ( EGFR ) inhibitor More one prior chemotherapy treatment Clinically significant cardiac disease Major surgery within 4 week start study treatment Evidence central nervous system ( CNS ) metastases carcinomatous meningitis history uncontrolled seizure , central nervous system disorder . Uncontrolled serious medical psychiatric illness Pregnant breastfeeding woman Other active malignancy Inability swallow tablet evidence gastrointestinal malabsorption syndrome Known severe hypersensitivity Iressa Concomitant use phenytoin , carbamazepine , barbiturate , rifampicin , phenobarbital , St. John 's wort . History severe hypersensitivity reaction drug formulate polysorbate 80 Any evidence clinically active interstitial lung disease Ascites require paracentesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Pancreatic Carcinoma</keyword>
	<keyword>Iressa</keyword>
	<keyword>Docetaxel</keyword>
</DOC>